Integrated Wealth Concepts LLC Has $12.57 Million Position in Philip Morris International Inc. $PM

Integrated Wealth Concepts LLC boosted its stake in shares of Philip Morris International Inc. (NYSE:PM) by 13.3% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 69,466 shares of the company’s stock after purchasing an additional 8,154 shares during the period. Integrated Wealth Concepts LLC’s holdings in Philip Morris International were worth $12,568,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Capital World Investors boosted its stake in shares of Philip Morris International by 2.8% during the 4th quarter. Capital World Investors now owns 132,355,726 shares of the company’s stock valued at $21,230,315,000 after buying an additional 3,579,399 shares during the period. BlackRock Inc. grew its holdings in shares of Philip Morris International by 0.4% during the 2nd quarter. BlackRock Inc. now owns 108,039,522 shares of the company’s stock valued at $19,545,430,000 after acquiring an additional 444,449 shares in the last quarter. Capital International Investors increased its stake in shares of Philip Morris International by 13.7% in the fourth quarter. Capital International Investors now owns 101,377,875 shares of the company’s stock worth $16,262,967,000 after acquiring an additional 12,227,004 shares during the last quarter. Capital Research Global Investors increased its stake in shares of Philip Morris International by 25.3% in the fourth quarter. Capital Research Global Investors now owns 54,559,706 shares of the company’s stock worth $8,751,407,000 after acquiring an additional 11,013,173 shares during the last quarter. Finally, GQG Partners LLC purchased a new stake in shares of Philip Morris International during the second quarter worth $8,220,008,000. Institutional investors and hedge funds own 78.63% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. UBS Group lifted their price objective on Philip Morris International from $168.00 to $182.00 and gave the company a “neutral” rating in a research report on Thursday, July 2nd. Citigroup upped their target price on Philip Morris International from $210.00 to $225.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Barclays raised their price target on Philip Morris International from $205.00 to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 29th. Stifel Nicolaus lifted their price target on Philip Morris International from $195.00 to $205.00 and gave the company a “buy” rating in a report on Thursday, July 23rd. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Philip Morris International in a research note on Monday, August 17th. Ten research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $205.89.

Philip Morris International News Summary

Here are the key news stories impacting Philip Morris International this week:

• Positive Sentiment: Higher 2026 earnings outlook: Philip Morris raised its 2026 adjusted diluted EPS forecast to $8.35-$8.50, with the increase attributed to currency tailwinds rather than a change to its underlying operational outlook. The guidance supports investor confidence and is above the company’s previous expectations. Philip Morris Raises 2026 Earnings Guidance Amid Currency Tailwinds
• Positive Sentiment: ZYN portfolio expansion: PMI’s U.S. business is broadening ZYN with new 1.5 mg and 8 mg strengths, the higher-moisture ZYN ULTRA line, additional flavors and formats, and more pouches per can. The expanded range could attract more legal-age adult nicotine consumers and support volume growth. PMI U.S. Expands ZYN Portfolio to Offer Adults More Smoke-Free Choices
• Positive Sentiment: Regulatory support for nicotine pouches: FDA authorization for 11 ZYN products, including higher-strength ZYN ULTRA offerings, strengthens PMI’s position in the fast-growing U.S. nicotine-pouch market and provides a foundation for scaling production after substantial manufacturing investments. FDA Authorization Expands Philip Morris’s Zyn Bet, Can It Pay Off?
• Neutral Sentiment: Execution remains important: The ZYN rollout is strategically favorable, but the earnings benefit will depend on consumer adoption, manufacturing capacity and the company’s ability to convert product expansion into sustainable sales and profit growth.

Philip Morris International Trading Up 0.5%

Philip Morris International stock opened at $185.71 on Thursday. Philip Morris International Inc. has a 1-year low of $142.11 and a 1-year high of $207.76. The firm’s fifty day simple moving average is $188.25 and its 200-day simple moving average is $178.77. The company has a market capitalization of $289.45 billion, a P/E ratio of 26.68, a P/E/G ratio of 2.37 and a beta of 0.37.

Philip Morris International (NYSE:PM) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $2.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.05 by $0.15. The firm had revenue of $11.19 billion during the quarter, compared to analysts’ expectations of $10.60 billion. Philip Morris International had a net margin of 11.06% and a negative return on equity of 163.41%. Philip Morris International’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.89 earnings per share. Philip Morris International has set its Q3 2026 guidance at 2.200-2.25 EPS. On average, equities research analysts predict that Philip Morris International Inc. will post 8.39 earnings per share for the current year.

About Philip Morris International

Philip Morris International Inc is a global tobacco and nicotine company headquartered in Stamford, Connecticut. The company develops, manufactures and markets cigarettes, smoke-free products, nicotine products and related consumer offerings in markets around the world.

Its portfolio includes internationally recognized cigarette brands such as Marlboro, Parliament, L&M and Chesterfield. PMI is also expanding beyond traditional cigarettes through heated-tobacco products, including IQOS, e-vapor products such as VEEV, and oral nicotine products including ZYN, which became part of the company’s portfolio following its acquisition of Swedish Match.

Philip Morris International was established as an independent company in 2008 after being separated from Altria Group, whose U.S.